Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
- Issued Date
- 2021
- Type
- Article
- Publisher
- BMJ OPEN
- Language
- 영어
- ISSN
- 2044-6055
- Citation Volume
- 11
- Citation Number
- 1
- Citation Start Page
- 0
- Citation End Page
- 0
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.